Urgent.News

What's breaking now, across thousands of outlets.

Business

Outlook Therapeutics Names Greg DiPasquale Chief Commercial Officer

(RTTNews) - On Friday, Outlook Therapeutics (OTLK), a biopharmaceutical company developing and commercializing LYTENAVA for retinal diseases, announced Greg DiPasquale as Chief Commercial Officer.

We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.

Read the original at nasdaq.com →

More in Business

More from Friday 9 October →